sj-docx-1-nah-10.1177_02601060231187924 - Supplemental material for Vegan and vegetarian males and females have higher orthorexic traits than omnivores, and are motivated in their food choice by factors including ethics and weight control

Supplemental material, sj-docx-1-nah-10.1177_02601060231187924 for Vegan and vegetarian males and females have higher orthorexic traits than omnivores, and are motivated in their food choice by factors including ethics and weight control by Rebecca Reynolds, Andrea McGowan, Sophie Smith and Patrick Rawstorne in Nutrition and Health</p

Additional file 1: of Web-based interventions for prevention and treatment of perinatal mood disorders: a systematic review

Systematic Search Strategies. Full search strategies of all databases used within the systematic review. (PDF 107 kb

Lettres d'un voyageur. Partie 1

Contient une table des matièresAvec mode text

Additional file 2: of The epigenetic clock and pubertal, neuroendocrine, psychiatric, and cognitive outcomes in adolescents

Figure S1. A scatterplot with a regression lines showing associations between epigenetic age acceleration and salivary cortisol awakening response in 11.0–13.2-year-old adolescent boys and girls. Epigenetic age acceleration is calculated as the residual from a linear regression where DNA methylation age is regressed on chronological age and adjusted for 6 cell types. Numbers showing percent increase in salivary cortisol upon awakening per 1 year increase in epigenetic age acceleration and 95% confidence intervals are derived from generalized linear models with Gaussian reference distribution and adjusted for three multidimensional scaling components from genome-wide data and time upon awakening. (PPTX 38 kb

Additional file 1: of The epigenetic clock and pubertal, neuroendocrine, psychiatric, and cognitive outcomes in adolescents

Table S1. Associations between epigenetic age acceleration and covariates in 11.0–13.2-year-old adolescents. Table S2. Associations between epigenetic age acceleration and cognition in 11.0–13.2-year-old adolescents. (DOCX 17 kb

Additional file 1: Figure S1. of Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial

Algorithm for glibenclamide dose adjustment. (DOCX 63 kb

Additional file 2: Table S1. of Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial

Secondary outcomes – Glycaemic control. Table S2. Clinical outcomes – Mother Table S3. Secondary outcomes – Clinical outcomes (infant). (DOCX 52 kb

Additional file 1: Figure S1. of Associations between maternal risk factors of adverse pregnancy and birth outcomes and the offspring epigenetic clock of gestational age at birth

Flowchart of the study participants and sample attrition. (PPTX 38 kb